Joshua James Burkart

Joshua James Burkart

Auto-generated profile, based on publicly available information

Joshua James Burkart

Cerebrovascular Concussion Laboratory, Faculty of Kinesiology, University of Calgary, Calgary, Alberta, Canada

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2024 in Applied Physiology, Nutrition, and Metabolism
Verified
Journal Article
Closed access
JBJoshua J. Burkart
Joshua J. Burkart
NJNathan E. Johnson
Nathan E. Johnson
JBJoel S Burma
Joel S Burma
MNMatthew G Neill
Matthew G Neill
JSJonathan Smirl
Jonathan Smirl
Cerebral hemodynamics have been quantified during exercise via transcranial Doppler ultrasound, as it has high-sensitivity to movement artifacts and displays temporal superiority. Currently, limited research exists regarding how different exercise modalities and postural changes impact the cerebrovasculature across the cardiac cycle. Ten participants (4 females and 6 males) ages 20–29 completed three exercise tests (treadmill, supine, and upright cycling) to volitional fatigue. Physiological data collected included middle cerebral artery velocity (MCAv), blood pressure (BP), heart rate, and respiratory parameters. Normalized data were analyzed for variance and effect sizes were calculated to examine differences between physiological measures across the three exercise modalities. Systolic MCAv was greater during treadmill compared to supine and upright cycling ( p < 0.001, (large) effect size), and greater during upright versus supine cycling ( p < 0.017, (large)). Diastolic MCAv was lower during treadmill versus cycling exercise only at 60% maximal effort ( p < 0.005, (moderate)) and no differences were observed between upright and supine cycling. No main effect was found for mean and diastolic BP ( p > 0.05, (negligible)). Systolic BP was lower during treadmill versus supine cycling at 40% and 60% intensity ( p < 0.05, (moderate–large)) and greater during supine versus upright at only 60% intensity ( p < 0.003, (moderate)). The above differences were not explained by partial pressure of end-tidal carbon dioxide levels (main effect: p = 0.432) . The current study demonstrates the cerebrovascular and cardiovascular systems respond heterogeneously to different exercise modalities and aspects of the cardiac cycle. As physiological data were largely similar between tests, differences associated with posture and modality are likely contributors.

23 June 2025 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
GKGregory A Kline
Gregory A Kline
JLJoshua Low
Joshua Low
JBJoshua James Burkart
Joshua James Burkart
XHXun Yang Hu
Xun Yang Hu
KMKaitlyn Mellor
Kaitlyn Mellor
Alexander K.C. LeungAlexander K.C. Leung
Alexander K.C. Leung
Context: Biochemical screening for endocrine hypertension may be complex; the known presence of an adrenal mass markedly increases the pretest probability for adrenal hypertension and may inform diagnostic efforts. Objective: Model the potential incidence of adrenal masses that may be detected by routine adrenal imaging in patients with suspected endocrine hypertension. Design: Retrospective cohort study. Setting: Provincial administrative and clinical databases for radiology and biochemistry, Alberta, Canada. Participants: Patients with hypertension and any measurement of aldosterone-renin ratio (ARR), 2012 to 2019. Main Measures: Radiology report of any computed tomography or magnetic resonance imaging abdomen performed for any reason 0 to 12 years following ARR. Patients with any pre-ARR imaging data between 2002 and 2024 were excluded. The presence of adrenal mass, size, and density were recorded and stratified by imaging indication. Results: Of 6942 unique hypertension patients with ARR, 1462 (21%) had imaging done at some point after ARR, 912 (62.4%) for indications unrelated to hypertension/adrenal and at a median 771 days (69-1577) post ARR. The incidence rate estimate was 7.2% (5.6-9.2%) of scans showed adrenal mass, median 1.4 cm (1.1-2.3), a rate well above the modern series of adrenal incidentaloma prevalence in unselected adults. The number needed to screen in this population was 14 (11-18) to detect an adrenal mass without a priori indication for adrenal imaging. Conclusion: Among patients screened for PA but without prior or subsequent directed adrenal imaging, 1 in 14 were later found to have an adrenal mass on imaging done for other indications. Given the impact on pretest probability for endocrine hypertension and further investigation steps, routine adrenal imaging might be considered whenever PA suspicion is high.

1 May 2026 in Hypertension
Verified
Journal Article
Closed access
Alexander K.C. LeungAlexander K.C. Leung
Alexander K.C. Leung
JBJoshua J. Burkart
Joshua J. Burkart
JLJoshua Christopher Low
Joshua Christopher Low
LHLeo Hu
Leo Hu
KMKaitlyn Mellor
Kaitlyn Mellor
GKGregory A. Kline
Gregory A. Kline
BACKGROUND: Prior retrospective studies of aldosterone-renin ratio (ARR) measures were confounded by selection bias. METHODS: To define ARR sensitivity independent of case definition, administrative health and diagnostic imaging repositories in Alberta, Canada, were used to construct a 5-component definition for primary aldosteronism (PA) for the most easily recognizable cases. Components included hypertension, hypokalemia, adrenal mass, suppressed renin, and nonsuppressed aldosterone. ARR was omitted from the definition, permitting independent evaluation of the ARR using receiver operating characteristic curve analysis. The definition was validated by adrenal vein sampling and surgical outcomes. RESULTS: Of 931 adrenal vein sampling patients, 19.2% met the 5-component PA case definition; of these, 86.8% had unilateral disease, and of the 76.8% who underwent surgery, 91.2% achieved complete biochemical response. Between 2012 and 2019, 6717 patients with hypertension had ARR measured; 60.9% had computed tomography or magnetic resonance imaging performed for any reason. The prevalence of the 5-component PA cases was 4.8% by direct renin concentration and 6.6% by plasma renin activity. The area under the receiver operating characteristic curve for the ARR was 0.84 (0.81–0.86) and 0.82 (0.78–0.85) when direct renin concentration and plasma renin activity were used. The 90% sensitivity ARR threshold for the 5-component PA case definition was 26 pmol/mIU (direct renin) and 350 pmol/ng per mL/h (renin activity), with specificities of 60% and 56%. At 5% prevalence rates, positive predictive values were 11% and 10%. Commonly recommended ARR screening thresholds of 70 pmol/mIU or 550 pmol/ng per mL/h had sensitivities of 68% and 82%, respectively, for a surgically relevant PA phenotype. CONCLUSIONS: Current ARR thresholds have low-to-moderate sensitivity for cases of PA where adrenal vein sampling and surgery are strong considerations.

19 March 2026 in Experimental Physiology
Verified
Journal Article
Open access
JSJonathan D. Smirl
Jonathan D. Smirl
JBJoshua J. Burkart
Joshua J. Burkart
MNMatthew G Neill
Matthew G Neill
JGJean‐Michel Galarneau
Jean‐Michel Galarneau
EFElizabeth K. S. Fletcher
Elizabeth K. S. Fletcher
CECarolyn A. Emery
Carolyn A. Emery
Aerobic exercise testing helps facilitate recovery post‐concussion. Current protocols (Calgary Concussion Cycling Test: CCCT) are inaccessible for athletes with lower‐body impairments (i.e. Para athletes). This study compared physiological parameters for a novel arm crank test, the Calgary Adapted aRm Ergometer (CARE) test, with the CCCT. Twenty non‐disabled adults (10F:10M, aged 18–51) completed CCCT and CARE to volitional fatigue. Middle cerebral artery velocity (MCAv), heart rate (HR), mean arterial pressure (MAP) and end‐tidal carbon dioxide () were continuously measured throughout exertion. Bland–Altman with 95% limits‐of‐agreement (LoA), mean differences with effect size measurement and intraclass correlation (ICC) compared CCCT to CARE at 25%, 50%, 75% and 100% of test exertion levels. Test duration was comparable between protocols ( P = 0.86). HR mean differences between CCCT and CARE ranged from 2 bpm ( P = 0.45) at 25% to 8 bpm ( P  < 0.05) at 100% effort level (negligible‐to‐medium effect sizes). MCAv mean differences increased from 1.5 cm/s at 25% ( P = 0.45) to 5.4 cm/s at 100% effort ( P  < 0.05) (small effect sizes). MAP remained stable: 4.1 mmHg at 25% ( P = 0.11) and 4.8 mmHg at 100% effort ( P = 0.076) (small effect sizes). mean differences increased until 75% effort level (2.4 to 4.9 Torr, P  < 0.05, medium‐to‐large effect size). ICC was good‐to‐moderate across all measurements with 95% LoA widening with increased test intensity. The CARE test represents a promising alternative to traditional lower body exercise tests, demonstrating robust physiological responses and moderate comparability with the CCCT. CARE vs. CCCT differences likely resulted from different total muscle mass engagement between the upper and lower body.

6 February 2026 in medRxiv
Verified
Preprint
Open access
PDF file
ALAa Leung
Aa Leung
SPStefan J Przybojewski
Stefan J Przybojewski
MKMartin Klamrowski
Martin Klamrowski
CCC Caughlin
C Caughlin
CWChristopher Wright
Christopher Wright
LHLeo Hu
Leo Hu
Background: Primary aldosteronism(PA) screening is recommended but disease prevalence exceeds the availability of adrenal vein sampling(AVS). Methods: An AVS optimal allocation tool for health systems was developed using administrative data and AVS registries from Calgary and Taiwan. Four easily-definable phenotypes of PA based on an elevated aldosterone-renin-ratio (ARR), and the presence/absence of hypokalemia or adrenal mass were identified, representing progressively severe PA and stepwise increasing rates of AVS-defined lateralization. Using supply-and-demand principles, a customizable, web-based tool was developed that considers PA referral volume, PA phenotype prevalence, maximum AVS available/year, AVS success rate, and desired rate of finding unilateral disease. Results: The most prevalent phenotype of PA was characterized by an elevated ARR and hypokalemia but no adrenal mass (41.9 [39.9–43.9]%); hypokalemia and adrenal mass accounted for (15.6[14.4-16.9]%) of cases. There was a progressive increase in AVS lateralization rate with increasing severity of phenotype observed in both the Calgary and Taiwan data, ranging from (20-39%) in those with PA without hypokalemia or adrenal mass to (70-90%) in those with hypokalemia and adrenal mass. After accounting for institution-specific lateralization rates and allowing for system-level differences in high- and low-volume PA referrals, and high- and low AVS availability, the customizable AVS allocation tool was able to generate individualized strategies ranging from restrictive (exclusive reservation of AVS for cases with hypokalemia and adrenal mass) to more inclusive strategies (assigning a proportion of AVS allocation to less severe PA cases). Conclusions: An AVS allocation tool that uses common, simple, and globally available PA case data may assist in health system AVS program case allocation for maximum equity and wait-list control. GRAPHICAL

9 July 2026 in Experimental Physiology
Verified
Journal Article
Open access
JBJoshua J. Burkart
Joshua J. Burkart
MNMatthew G Neill
Matthew G Neill
JGJean‐Michel Galarneau
Jean‐Michel Galarneau
TWTegan Wilder
Tegan Wilder
SJSarah Johns
Sarah Johns
JSJonathan D. Smirl
Jonathan D. Smirl
Exertion testing helps inform exercise prescription during concussion recovery. The Calgary Adapted aRm Ergometer (CARE) test, developed as the first upper‐body specific exertion test, aims to improve accessibility and inclusivity in concussion care. While initial development was conducted in adults, its applicability in adolescents remains unknown. This study compared physiological responses between the CARE test and the Calgary Concussion Cycle Test (CCCT) in non‐disabled adolescent male and female athletes. Fifteen females and fifteen males (aged 14–17) performed CARE and CCCT to volitional fatigue. Response differences, Bland–Altman plots, effect sizes, intraclass correlation and moderation by sex for heart rate (HR), middle cerebral artery velocity (MCAv), volume of oxygen consumption (), minute ventilation () and end‐tidal carbon dioxide () were analysed at 25%, 50%, 75% and 100% of peak exertion levels. CARE elicited lower absolute values for HR, MCAv, , and compared to CCCT, with differences and 95% limits‐of‐agreement becoming more pronounced at higher intensities. For mild‐to‐moderate exercise (25–50% exertion), the range typically used in clinical concussion testing, HR and MCAv differences were small for both sexes. Near maximal intensity, the HR gap widened, but MCAv was comparable. Sex did not modify the relationship between tests for HR and MCAv. While CARE predominantly employs smaller muscle mass than CCCT, results showed robust and relatively comparable physiological responses between tests and between male and female adolescents. These findings further support CARE as an accessible and inclusive post‐concussion exertion test for those not able to perform lower‐body protocols.